Related Experiment Video
Updated: May 26, 2025

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Talaromyketides A-I: Nine polyketides with anti-inflammatory activity from a soil fungus Talaromyces sp. KYS-41
Dong-Xue Jia1, Ying Li2, Xiang-Yu Liu2
1Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong 264117, China.
Abstract:
A chemical investigation into fermentation product of Talaromyces sp. KYS-41, a fungus isolated from Kunyu Mountain soil, resulted in the discovery and identification of 27 polyketides. Notably, talaromyketides A-I (1-9) are reported for the first time, with talaromyketides A-C (1-3) being three pair of enantiomers. Talaromyketides A-D (1-4) display novel frameworks and are regarded as products resulting from oxidative ring-opening and/or subsequent rearrangement of the bibenzyl derivatives. Talaromyketide A (1) exhibits a scaffold comprising an isochroman-1,4-dione, whereas talaromyketide B (2) showcases the structural backbone of a naphthalen-1(4H)-one. Talaromyketides C (3) and D (4) are the outcomes of oxidative ring-opening of one of the phenyl rings in bibenzyl derivatives. Biological evaluations demonstrated that compounds 2b, 9, and 18-21 show significant anti-inflammatory activity with IC50 values within 10 μM. By inhibiting the activation of NF-κB/MAPK signaling pathways, (-)-1S-talaromyketide B (2b) is involved in suppression of inflammatory response and shows significant pharmacological effects in vivo on zebrafish model.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

